Free Account Opening + AMC Free Demat
Loading...

Alkem Laboratories IPO vs Sadbhav Infra IPO

Comparision between Alkem Laboratories IPO and Sadbhav Infra IPO.

IPO Details

Alkem Laboratories IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Sadbhav Infra IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Alkem Laboratories IPO is up to ₹1,349.61 Cr whereas the issue size of the Sadbhav Infra IPO is up to ₹491.66 Cr. The final issue price of Alkem Laboratories IPO is ₹1,050.00 per share and of Sadbhav Infra IPO is ₹103.00 per share.

  Alkem Laboratories IPO Sadbhav Infra IPO
Face Value ₹2 per share ₹10 per share
Issue Price (Lower) ₹1,020.00 per share ₹100.00 per share
Issue Price (Upper) ₹1,050.00 per share ₹103.00 per share
Issue Price (Final) ₹1,050.00 per share ₹103.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 14 shares 145 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹425.00 Cr
OFS Issue Size 64,71,524 shares
OFS Issue Size (Amount)
Issue Size Total 1,28,53,442 shares
Issue Size Total (Amount) up to ₹1,349.61 Cr up to ₹491.66 Cr

IPO Timetable

Alkem Laboratories IPO opens on Dec 08, 2015, while Sadbhav Infra IPO opens on Aug 31, 2015. The closing date of Alkem Laboratories IPO and Sadbhav Infra IPO is Dec 10, 2015, and Sep 02, 2015, respectively.

  Alkem Laboratories IPO Sadbhav Infra IPO
Anchor Bid Date
Issue Open Dec 08, 2015 Aug 31, 2015
Issue Close Dec 10, 2015 Sep 02, 2015
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Alkem Laboratories IPO P/E ratio is , as compared to Sadbhav Infra IPO P/E ratio of .

  Alkem Laboratories IPO Sadbhav Infra IPO
Financial
ParticularsFor the year/period ended (in Rs. Million)
31 Mar 1531 Mar 1431 Mar 1331 Mar 12
Total Income33,595.2028,395.8024,690.1020,640.10
Profit After Tax (PAT)4,370.904,402.004,667.804,318.10
ParticularsFor the year/period ended (in Rs. Million)
31 Mar 1531 Mar 1431 Mar 1331 Mar 12
Total Income5,280.493,926.603,154.251,987.48
Profit After Tax (PAT)-3,015.61-1,559.37-456.6697.99
Promoter Shareholding (Pre-Issue) 70.87%
Promoter Shareholding (Post-Issue) 66.23%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW 15.4%%

Shares Offered

In the Alkem Laboratories IPO retail investors (RII) are offered 43,94,086 shares while in Sadbhav Infra IPO retail investors are offered 43,94,086 shares. Qualified institutional buyers (QIB) are offered 25,10,906 shares in Alkem Laboratories IPO and 1,44,65,730 shares in Sadbhav Infra IPO.

  Alkem Laboratories IPO Sadbhav Infra IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 25,10,906 shares 1,44,65,730 shares
NII 18,83,179 shares 69,70,728 shares
RII 43,94,086 shares 46,47,152 shares
Employee 2,98,913 shares 25,00,000 shares
Others
Total 90,87,084 shares 2,85,83,610 shares

Bids Received (Subscription)

Alkem Laboratories IPO subscribed 44.29x in total, whereas Sadbhav Infra IPO subscribed 2.24x.

  Alkem Laboratories IPO Sadbhav Infra IPO
QIB (times) 57.19x 3.04x
NII (times) 129.96x 1.66x
Big NII (times)
Small NII (times)
RII (times) 3.17x 1.69x
Employee (times) 0.67x 0.29x
Other (times)
Total (times) 44.29x 2.24x

Comments

Add a public comment...